Experimental Alopecia Pill Shows Promise

If results of a new Phase 3 study are successful, Concert Pharmaceuticals will likely submit the drug for FDA approval next year.

Concert Pharmaceutical
Concert Pharmaceuticals

If this year’s Oscars did anything, it put the severe form of hair loss known as alopecia in the limelight. The disease causes the body’s immune system to attack hair follicles, resulting in patchy hair loss, or in some cases total hair loss. Currently, there are no approved treatments for the disease. But according to a recent Boston Globe article, those afflicted with the condition have new hope in the form of a pill. An experimental treatment from Concert Pharmaceuticals has restored a near full head of hair in roughly 30-40% of people with alopecia.

Recyclable pill bottles are gaining pharmacy ground
Aluminum and paper-based prescription bottles are moving from concept to commercial reality. Here's what pharmacy and packaging leaders need to know.
Read More
Recyclable pill bottles are gaining pharmacy ground
Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026